Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. IPharmaceuticals/I 2023, I16/I, 1164
Gespeichert in:
Veröffentlicht in: | Pharmaceuticals (Basel, Switzerland) Switzerland), 2023-11, Vol.16 (11) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 11 |
container_start_page | |
container_title | Pharmaceuticals (Basel, Switzerland) |
container_volume | 16 |
creator | Joseph, Boney Nunez, Nicolas A Kung, Simon Vande Voort, Jennifer L Pazdernik, Vanessa K Schak, Kathryn M Boehm, Stacey M Carpenter, Brooke Johnson, Emily K Malyshev, Grigoriy Smits, Nathan Adewunmi, Daniel O Brown, Sarah K Singh, Balwinder |
description | |
doi_str_mv | 10.3390/ph16111571 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A774324785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A774324785</galeid><sourcerecordid>A774324785</sourcerecordid><originalsourceid>FETCH-LOGICAL-g675-5b68a6a09f1e099f01b6e2aa0c6d953c8b3a46fc44c79a471ba7ff6a4cfa67c93</originalsourceid><addsrcrecordid>eNptUMFOAjEQ3RhNRPTiF0zilYV2t9uy3giirpJICHcylCnUsLukrTF8kn9pRQ8czBzmZd6b9zKTJLec9fO8ZIP9lkvOeaH4WdLhIhPpMBPq_ARfJlfevzMWJYJ3kq9x6xzpYNvmHl5aT_stUADc9WFijNWoD9AaeKWAtW0IPm3YAjbrI2g_AkyxboOzmx_SNrBwhKGmJqRz8tYHbAI80N6R98eIEcwc7Wz0QneAOe1bF_pQzbboatT0EWLkzg8qyFiW96DiclD1gHMprpMLEym6-evdZPE4WYyf0-nbUzUeTdONVEVarOQQJbLScGJlaRhfScoQmZbrssj1cJWjkEYLoVWJQvEVKmMkCm1QKl3m3eTu13aDO1raxsTrUNfW6-VIKZHHFw6LqOr_o4q1ptrqtiFj4_xk4RutH31h</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. IPharmaceuticals/I 2023, I16/I, 1164</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Joseph, Boney ; Nunez, Nicolas A ; Kung, Simon ; Vande Voort, Jennifer L ; Pazdernik, Vanessa K ; Schak, Kathryn M ; Boehm, Stacey M ; Carpenter, Brooke ; Johnson, Emily K ; Malyshev, Grigoriy ; Smits, Nathan ; Adewunmi, Daniel O ; Brown, Sarah K ; Singh, Balwinder</creator><creatorcontrib>Joseph, Boney ; Nunez, Nicolas A ; Kung, Simon ; Vande Voort, Jennifer L ; Pazdernik, Vanessa K ; Schak, Kathryn M ; Boehm, Stacey M ; Carpenter, Brooke ; Johnson, Emily K ; Malyshev, Grigoriy ; Smits, Nathan ; Adewunmi, Daniel O ; Brown, Sarah K ; Singh, Balwinder</creatorcontrib><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph16111571</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Depression, Mental ; Drug therapy ; Ketamine ; Lamotrigine</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2023-11, Vol.16 (11)</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27922,27923</link.rule.ids></links><search><creatorcontrib>Joseph, Boney</creatorcontrib><creatorcontrib>Nunez, Nicolas A</creatorcontrib><creatorcontrib>Kung, Simon</creatorcontrib><creatorcontrib>Vande Voort, Jennifer L</creatorcontrib><creatorcontrib>Pazdernik, Vanessa K</creatorcontrib><creatorcontrib>Schak, Kathryn M</creatorcontrib><creatorcontrib>Boehm, Stacey M</creatorcontrib><creatorcontrib>Carpenter, Brooke</creatorcontrib><creatorcontrib>Johnson, Emily K</creatorcontrib><creatorcontrib>Malyshev, Grigoriy</creatorcontrib><creatorcontrib>Smits, Nathan</creatorcontrib><creatorcontrib>Adewunmi, Daniel O</creatorcontrib><creatorcontrib>Brown, Sarah K</creatorcontrib><creatorcontrib>Singh, Balwinder</creatorcontrib><title>Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. IPharmaceuticals/I 2023, I16/I, 1164</title><title>Pharmaceuticals (Basel, Switzerland)</title><subject>Depression, Mental</subject><subject>Drug therapy</subject><subject>Ketamine</subject><subject>Lamotrigine</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptUMFOAjEQ3RhNRPTiF0zilYV2t9uy3giirpJICHcylCnUsLukrTF8kn9pRQ8czBzmZd6b9zKTJLec9fO8ZIP9lkvOeaH4WdLhIhPpMBPq_ARfJlfevzMWJYJ3kq9x6xzpYNvmHl5aT_stUADc9WFijNWoD9AaeKWAtW0IPm3YAjbrI2g_AkyxboOzmx_SNrBwhKGmJqRz8tYHbAI80N6R98eIEcwc7Wz0QneAOe1bF_pQzbboatT0EWLkzg8qyFiW96DiclD1gHMprpMLEym6-evdZPE4WYyf0-nbUzUeTdONVEVarOQQJbLScGJlaRhfScoQmZbrssj1cJWjkEYLoVWJQvEVKmMkCm1QKl3m3eTu13aDO1raxsTrUNfW6-VIKZHHFw6LqOr_o4q1ptrqtiFj4_xk4RutH31h</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Joseph, Boney</creator><creator>Nunez, Nicolas A</creator><creator>Kung, Simon</creator><creator>Vande Voort, Jennifer L</creator><creator>Pazdernik, Vanessa K</creator><creator>Schak, Kathryn M</creator><creator>Boehm, Stacey M</creator><creator>Carpenter, Brooke</creator><creator>Johnson, Emily K</creator><creator>Malyshev, Grigoriy</creator><creator>Smits, Nathan</creator><creator>Adewunmi, Daniel O</creator><creator>Brown, Sarah K</creator><creator>Singh, Balwinder</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20231101</creationdate><title>Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. IPharmaceuticals/I 2023, I16/I, 1164</title><author>Joseph, Boney ; Nunez, Nicolas A ; Kung, Simon ; Vande Voort, Jennifer L ; Pazdernik, Vanessa K ; Schak, Kathryn M ; Boehm, Stacey M ; Carpenter, Brooke ; Johnson, Emily K ; Malyshev, Grigoriy ; Smits, Nathan ; Adewunmi, Daniel O ; Brown, Sarah K ; Singh, Balwinder</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g675-5b68a6a09f1e099f01b6e2aa0c6d953c8b3a46fc44c79a471ba7ff6a4cfa67c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Depression, Mental</topic><topic>Drug therapy</topic><topic>Ketamine</topic><topic>Lamotrigine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joseph, Boney</creatorcontrib><creatorcontrib>Nunez, Nicolas A</creatorcontrib><creatorcontrib>Kung, Simon</creatorcontrib><creatorcontrib>Vande Voort, Jennifer L</creatorcontrib><creatorcontrib>Pazdernik, Vanessa K</creatorcontrib><creatorcontrib>Schak, Kathryn M</creatorcontrib><creatorcontrib>Boehm, Stacey M</creatorcontrib><creatorcontrib>Carpenter, Brooke</creatorcontrib><creatorcontrib>Johnson, Emily K</creatorcontrib><creatorcontrib>Malyshev, Grigoriy</creatorcontrib><creatorcontrib>Smits, Nathan</creatorcontrib><creatorcontrib>Adewunmi, Daniel O</creatorcontrib><creatorcontrib>Brown, Sarah K</creatorcontrib><creatorcontrib>Singh, Balwinder</creatorcontrib><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joseph, Boney</au><au>Nunez, Nicolas A</au><au>Kung, Simon</au><au>Vande Voort, Jennifer L</au><au>Pazdernik, Vanessa K</au><au>Schak, Kathryn M</au><au>Boehm, Stacey M</au><au>Carpenter, Brooke</au><au>Johnson, Emily K</au><au>Malyshev, Grigoriy</au><au>Smits, Nathan</au><au>Adewunmi, Daniel O</au><au>Brown, Sarah K</au><au>Singh, Balwinder</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. IPharmaceuticals/I 2023, I16/I, 1164</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>16</volume><issue>11</issue><issn>1424-8247</issn><eissn>1424-8247</eissn><pub>MDPI AG</pub><doi>10.3390/ph16111571</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1424-8247 |
ispartof | Pharmaceuticals (Basel, Switzerland), 2023-11, Vol.16 (11) |
issn | 1424-8247 1424-8247 |
language | eng |
recordid | cdi_gale_infotracmisc_A774324785 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Depression, Mental Drug therapy Ketamine Lamotrigine |
title | Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. IPharmaceuticals/I 2023, I16/I, 1164 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A32%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Joseph%20et%20al.%20Efficacy%20of%20Ketamine%20with%20and%20without%20Lamotrigine%20in%20Treatment-Resistant%20Depression:%20A%20Preliminary%20Report.%20IPharmaceuticals/I%202023,%20I16/I,%201164&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Joseph,%20Boney&rft.date=2023-11-01&rft.volume=16&rft.issue=11&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph16111571&rft_dat=%3Cgale%3EA774324785%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A774324785&rfr_iscdi=true |